Cutlass Capital, L.L.C.
Venture capitalBoston · Seed–Late Stage · 1 people tracked
Find your way into Cutlass Capital, L.L.C.
Investment thesis
Cutlass Capital is a venture capital partnership that invests in healthcare companies. The firm operates as a private partnership.
Team · 1 people
from public directoriesFrequently asked questions
- What stage does Cutlass Capital, L.L.C. invest at?
- Cutlass Capital, L.L.C. invests at the Seed, Series A, Series B, Series C, Late Stage stages.
- What is Cutlass Capital, L.L.C.'s typical check size?
- Cutlass Capital, L.L.C. typically writes checks of $3M – $7M.
- What sectors does Cutlass Capital, L.L.C. focus on?
- Cutlass Capital, L.L.C. focuses on Healthtech, Medical Devices.
- Where is Cutlass Capital, L.L.C. located?
- Cutlass Capital, L.L.C. is headquartered in Boston, US.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Fluke Venture Partners is a Pacific Northwest venture firm that has funded technology, healthcare, and consumer companies for over three decades, working with management teams as long-term partners from early stages onward.
Vesalius Biocapital is a European life sciences venture capital investor focused on later-stage companies in drug development, medical devices and diagnostics, and eHealth/mHealth. Its active fund, Vesalius Biocapital III, closed in May 2019 with €120 million in commitments.
Roadmap Capital Inc. is an investment platform providing co-investment access to private companies in technology and healthcare/medtech sectors.